Treatment of Oral Thrush
For mild oral thrush, clotrimazole troches (10 mg 5 times daily) or miconazole mucoadhesive buccal tablets (50 mg once daily) for 7-14 days are recommended as first-line therapy, while moderate to severe cases should be treated with oral fluconazole (100-200 mg daily) for 7-14 days. 1, 2
Treatment Algorithm Based on Disease Severity
Mild Oral Thrush
- First-line options:
- Alternative options:
Moderate to Severe Oral Thrush
- Oral fluconazole, 100-200 mg daily for 7-14 days 1, 2
- Single-dose fluconazole 150 mg has shown efficacy in palliative care patients with oral thrush, with 96.5% showing >50% improvement in signs and symptoms 4
Fluconazole-Refractory Disease
- Itraconazole solution, 200 mg once daily for up to 28 days 1, 2
- Posaconazole suspension, 400 mg twice daily for 3 days then 400 mg daily for up to 28 days 1, 2
- Voriconazole, 200 mg twice daily 1, 2
- Amphotericin B deoxycholate oral suspension, 100 mg/mL 4 times daily 1, 2
Patients Unable to Tolerate Oral Therapy
- Intravenous echinocandin options 1, 2:
- Caspofungin: 70-mg loading dose, then 50 mg daily
- Micafungin: 100 mg daily
- Anidulafungin: 200-mg loading dose, then 100 mg daily
- Intravenous amphotericin B deoxycholate, 0.3 mg/kg daily 1, 2
Special Considerations
Denture-Related Candidiasis
- Disinfection of the denture in addition to antifungal therapy is essential 1, 2
- Dentures should be removed at night and cleaned thoroughly 2
HIV-Infected Patients
- Antiretroviral therapy is strongly recommended to reduce the incidence of recurrent infections 1, 2
- May require longer treatment courses or higher doses of antifungal medications 2
- Fluconazole has shown superiority over clotrimazole in HIV patients with better compliance due to once-daily dosing 5
Recurrent Oral Thrush
- For patients with recurrent infections, fluconazole 100 mg three times weekly is recommended for chronic suppressive therapy 1, 2
- Daily fluconazole (100 mg) has been shown to effectively prevent recurrent thrush in immunocompromised patients 6
Clinical Pearls and Pitfalls
- Fluconazole has demonstrated superior clinical cure rates compared to nystatin suspension in infants (100% vs 32%) 7
- Persistent or recurrent thrush despite appropriate therapy may indicate underlying immunodeficiency or resistance and warrants further investigation 8
- Clotrimazole acts by altering the permeability of fungal cell membranes and maintains therapeutic salivary levels for up to three hours after dissolution 9
- Treatment should be continued until clinical resolution of symptoms 2
- Azole-resistant C. albicans infections are extremely rare but can occur following prolonged azole exposure 1